Other Species / Isoforms
  KRas (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T2-p
______MtEykLVVV
0 1
KRas (human) ______MtEykLVVV T2-p
KRas iso2 (human) ______MTEYKLVVV T2
KRas (mouse) ______MTEYKLVVV T2
KRas iso2 (mouse) ______MTEYKLVVV T2
KRas (rat) ______MTEYKLVVV T2
Y4-p
____MtEykLVVVGA
0 1
KRas (human) ____MtEykLVVVGA Y4-p
KRas iso2 (human) ____MTEYKLVVVGA Y4
KRas (mouse) ____MTEYKLVVVGA Y4
KRas iso2 (mouse) ____MTEYKLVVVGA Y4
KRas (rat) ____MTEYKLVVVGA Y4
K5-m2
___MtEykLVVVGAG
1 1
KRas (human) ___MtEykLVVVGAG K5-m2
KRas iso2 (human) ___MTEYKLVVVGAG K5
KRas (mouse) ___MTEYKLVVVGAG K5
KRas iso2 (mouse) ___MTEYKLVVVGAG K5
KRas (rat) ___MTEYKLVVVGAG K5
Y32-p
QNHFVDEyDPTIEDs
Upstream
Downstream
2 12
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • phosphorylation
  • protein conformation
Effects on Biological Processes:
  • signaling pathway regulation
Kinase, in vitro:
  • Src (human)
Phosphatases, in vitro:
  • SHP-2 (human)
Putative in vivo kinases:
  • Src (human)
Putative upstream phosphatases:
  • SHP-2 (human)
KRas (human) QNHFVDEyDPTIEDs Y32-p
KRas iso2 (human) QNHFVDEYDPTIEDS Y32
KRas (mouse) QNHFVDEYDPTIEDs Y32
KRas iso2 (mouse) QNHFVDEYDPTIEDS Y32
KRas (rat) QNHFVDEYDPTIEDS Y32
S39-p
yDPTIEDsyRkQVVI
0 11
KRas (human) yDPTIEDsyRkQVVI S39-p
KRas iso2 (human) YDPTIEDSYRKQVVI S39
KRas (mouse) YDPTIEDsYRKQVVI S39-p
KRas iso2 (mouse) YDPTIEDSYRKQVVI S39
KRas (rat) YDPTIEDSYrkQVVI S39
Y40-p
DPTIEDsyRkQVVID
0 3
KRas (human) DPTIEDsyRkQVVID Y40-p
KRas iso2 (human) DPTIEDSYRKQVVID Y40
KRas (mouse) DPTIEDsYRKQVVID Y40
KRas iso2 (mouse) DPTIEDSYRKQVVID Y40
KRas (rat) DPTIEDSYrkQVVID Y40
R41
PTIEDsyRkQVVIDG
1 1
KRas (human) PTIEDsyRkQVVIDG R41
KRas iso2 (human) PTIEDSYRKQVVIDG R41
KRas (mouse) PTIEDsYRKQVVIDG R41
KRas iso2 (mouse) PTIEDSYRKQVVIDG R41
KRas (rat) PTIEDSYrkQVVIDG R41-m2
K42
TIEDsyRKQVVIDGE
1 1
KRas (human) TIEDsyRKQVVIDGE K42
KRas iso2 (human) TIEDSYRKQVVIDGE K42
KRas (mouse) TIEDsYRKQVVIDGE K42
KRas iso2 (mouse) TIEDSYRKQVVIDGE K42
KRas (rat) TIEDSYrkQVVIDGE K42-m2
K42-sm
TIEDsyRkQVVIDGE
1 0
KRas (human) TIEDsyRkQVVIDGE K42-sm
KRas iso2 (human) TIEDSYRKQVVIDGE K42
KRas (mouse) TIEDsYRKQVVIDGE K42
KRas iso2 (mouse) TIEDSYRKQVVIDGE K42
KRas (rat) TIEDSYrKQVVIDGE K42
Y64-p
DTAGQEEySAMRDQY
Upstream
Downstream
3 8
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
  • phosphorylation
  • protein conformation
Effects on Biological Processes:
  • cell growth, induced
  • signaling pathway regulation
Kinase, in vitro:
  • Src (human)
Phosphatases, in vitro:
  • SHP-2 (human)
Putative in vivo kinases:
  • Src (human)
Putative upstream phosphatases:
  • SHP-2 (human)
KRas (human) DTAGQEEySAMRDQY Y64-p
KRas iso2 (human) DTAGQEEYSAMRDQY Y64
KRas (mouse) DTAGQEEYSAMRDQY Y64
KRas iso2 (mouse) DTAGQEEYSAMRDQY Y64
KRas (rat) DTAGQEEYSAMRDQY Y64
S89-p
FAINNTKsFEDIHHy
0 1
KRas (human) FAINNTKsFEDIHHy S89-p
KRas iso2 (human) FAINNTKSFEDIHHY S89
KRas (mouse) FAINNTKSFEDIHHY S89
KRas iso2 (mouse) FAINNTKSFEDIHHY S89
KRas (rat) FAINNTKSFEDIHHY S89
Y96-p
sFEDIHHyREQIkRV
0 1
KRas (human) sFEDIHHyREQIkRV Y96-p
KRas iso2 (human) SFEDIHHYREQIKRV Y96
KRas (mouse) SFEDIHHYREQIKRV Y96
KRas iso2 (mouse) SFEDIHHYREQIKRV Y96
KRas (rat) SFEDIHHYREQIKRV Y96
K101-ac
HHyREQIkRVkDsED
0 1
KRas (human) HHyREQIkRVkDsED K101-ac
KRas iso2 (human) HHYREQIKRVkDSED K101
KRas (mouse) HHYREQIKRVkDSED K101
KRas iso2 (mouse) HHYREQIKRVKDSED K101
KRas (rat) HHYREQIKRVKDSED K101
K104-ac
REQIkRVkDsEDVPM
Upstream
Downstream
8 4
Effects on Modified Protein
  • activity, inhibited
  • enzymatic activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • apoptosis, induced
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, inhibited
Treatment
  • nicotinamide
  • siRNA
  • trichostatin_A
  • Tubastatin A
view more >
KRas (human) REQIkRVkDsEDVPM K104-ac
KRas iso2 (human) REQIKRVkDSEDVPM K104-ac
KRas (mouse) REQIKRVkDSEDVPM K104-ac
KRas iso2 (mouse) REQIKRVKDSEDVPM K104
KRas (rat) REQIKRVKDSEDVPM K104
K104-ub
REQIkRVkDsEDVPM
1 0
KRas (human) REQIkRVkDsEDVPM K104-ub
KRas iso2 (human) REQIKRVkDSEDVPM K104-ub
KRas (mouse) REQIKRVKDSEDVPM K104
KRas iso2 (mouse) REQIKRVKDSEDVPM K104
KRas (rat) REQIKRVKDSEDVPM K104
S106-p
QIkRVkDsEDVPMVL
0 1
KRas (human) QIkRVkDsEDVPMVL S106-p
KRas iso2 (human) QIKRVkDSEDVPMVL S106
KRas (mouse) QIKRVkDSEDVPMVL S106
KRas iso2 (mouse) QIKRVKDSEDVPMVL S106
KRas (rat) QIKRVKDSEDVPMVL S106
K117-ub
PMVLVGNkCDLPSRT
0 5
KRas (human) PMVLVGNkCDLPSRT K117-ub
KRas iso2 (human) PMVLVGNKCDLPSRT K117
KRas (mouse) PMVLVGNkCDLPSRT K117-ub
KRas iso2 (mouse) PMVLVGNKCDLPSRT K117
KRas (rat) PMVLVGNKCDLPSRT K117
K128-ac
PSRTVDTkQAQDLAR
0 1
KRas (human) PSRTVDTkQAQDLAR K128-ac
KRas iso2 (human) PSRTVDTKQAQDLAR K128
KRas (mouse) PSRTVDTKQAQELAR K128
KRas iso2 (mouse) PSRTVDTKQAQELAR K128
KRas (rat) PSRTVDTKQAQELAR K128
K128-ub
PSRTVDTkQAQDLAR
0 38
KRas (human) PSRTVDTkQAQDLAR K128-ub
KRas iso2 (human) PSRTVDTKQAQDLAR K128
KRas (mouse) PSRTVDTkQAQELAR K128-ub
KRas iso2 (mouse) PSRTVDTKQAQELAR K128
KRas (rat) PSRTVDTkQAQELAR K128-ub
T144-p
YGIPFIEtSAktRQR
Upstream
1 0
Treatment
  • KY1022
KRas (human) YGIPFIEtSAktRQR T144-p
KRas iso2 (human) YGIPFIETSAktRQG T144
KRas (mouse) YGIPFIETSAkTRQR T144
KRas iso2 (mouse) YGIPFIETSAKTRQG T144
KRas (rat) YGIPFIETSAKTRQR T144
K147-ac
PFIEtSAktRQRVED
1 2
KRas (human) PFIEtSAktRQRVED K147-ac
KRas iso2 (human) PFIETSAKtRQGVDD K147
KRas (mouse) PFIETSAkTRQRVED K147-ac
KRas iso2 (mouse) PFIETSAKTRQGVDD K147
KRas (rat) PFIETSAKTRQRVED K147
K147-ub
PFIEtSAktRQRVED
Downstream
2 9
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
KRas (human) PFIEtSAktRQRVED K147-ub
KRas iso2 (human) PFIETSAktRQGVDD K147-ub
KRas (mouse) PFIETSAkTRQRVED K147-ub
KRas iso2 (mouse) PFIETSAKTRQGVDD K147
KRas (rat) PFIETSAKTRQRVED K147
T148-p
FIEtSAktRQRVEDA
Upstream
1 1
Treatment
  • KY1022
KRas (human) FIEtSAktRQRVEDA T148-p
KRas iso2 (human) FIETSAktRQGVDDA T148-p
KRas (mouse) FIETSAkTRQRVEDA T148
KRas iso2 (mouse) FIETSAKTRQGVDDA T148
KRas (rat) FIETSAKTRQRVEDA T148
Y157-p
QRVEDAFyTLVREIR
0 17
KRas (human) QRVEDAFyTLVREIR Y157-p
KRas iso2 (human) QGVDDAFytLVREIR Y157-p
KRas (mouse) QRVEDAFYTLVREIR Y157
KRas iso2 (mouse) QGVDDAFYTLVREIR Y157
KRas (rat) QRVEDAFYTLVREIR Y157
T158
RVEDAFyTLVREIRQ
0 1
KRas (human) RVEDAFyTLVREIRQ T158
KRas iso2 (human) GVDDAFytLVREIRK T158-p
KRas (mouse) RVEDAFYTLVREIRQ T158
KRas iso2 (mouse) GVDDAFYTLVREIRK T158
KRas (rat) RVEDAFYTLVREIRQ T158
-
gap
0 1
KRas (human) gap -
KRas iso2 (human) KDGKKKKkKskTkCV K179-ac
KRas (mouse) gap -
KRas iso2 (mouse) KDGKKKKKKsRTRCT K179
KRas (rat) gap -
-
gap
9 0
KRas (human) gap -
KRas iso2 (human) GKKKKkKskTkCVIM S181-p
KRas (mouse) gap -
KRas iso2 (mouse) GKKKKKKsRTRCTVM S181-p
KRas (rat) gap -
-
gap
1 0
KRas (human) gap -
KRas iso2 (human) KKKKkKskTkCVIM_ K182-me
KRas (mouse) gap -
KRas iso2 (mouse) KKKKKKsRTRCTVM_ R182
KRas (rat) gap -
-
gap
1 0
KRas (human) gap -
KRas iso2 (human) KKkKskTkCVIM___ K184-me
KRas (mouse) gap -
KRas iso2 (mouse) KKKKsRTRCTVM___ R184
KRas (rat) gap -